Indian teenage swimmer, 17, banned 18 months for doping: A lesson on TUE

An Indian 17-year-old swimmer has been removed from the Asian Games squad and suspended for 18 months after testing positive for terbutaline—a bronchodilator commonly prescribed for asthma and bronchitis. The case highlights the fragile boundary between medical treatment and doping violations, especially for young athletes. The swimmer used the drug after suffering smoke inhalation, prescribed by a doctor, and listed it on the doping control form. However, he failed to obtain a Therapeutic Use Exemption (TUE) beforehand—a mandatory requirement for any substance on the prohibited list. Under WADA rules, a standard violation carries a four-year ban. This can be reduced to two years if unintentional doping is proven, with further reductions based on the athlete's ability to show reasonable explanation. The 18-month ban reflects the panel's acceptance of unintentional use while holding the athlete accountable for procedural non-compliance. A notable detail: the suspended swimmer has a twin brother who remains on the Asian Games team. Their similar names have often caused confusion in international meet reports. India, despite being the world's most populous nation, is not a sporting superpower. It won only six medals at the 2026 Olympics, with no golds. Yet the country consistently leads global anti-doping violations in recent years. This case underscores systemic issues: inadequate doping education for young athletes, and loose prescription oversight. For Vietnamese sports, the lesson is clear: proactive TUE procedures and strict compliance with WADA rules are essential to protect young talents from career-derailing mistakes. The swimmer still has a chance to return after 18 months, but only if the culture of compliance is strengthened.